Attorney General Misses Deadline For Rules To Make It Easier To Study Schedule I Drugs Like Marijuana And Psychedelics – Marijuana Moment
Attorney General Pam Bondi has missed a congressionally mandated deadline scheduled for January 16th to issue guidelines for easing barriers to research on Schedule I substances such as marijuana and psychedelics. Marijuana Moment covered the news featuring SSDP’s Executive Director’s take on the issue.
“This failure to act leaves researchers, institutions and regulators without clear guidance and directly contributes to research harm—the preventable damage caused when restrictive or unclear drug policies obstruct legitimate scientific research,” Kat Murti, executive director of Students for Sensible Drug Policy (SSDP), said in a press release on Tuesday. “Research harm delays medical innovation, limits evidence-based policymaking and slows the development of potential treatments for overdose, pain, addiction and mental health conditions.”
“Congress gave the attorney general a clear deadline and a clear mandate: reduce barriers to research while ensuring transparency and public input,” Murti said. “Missing this deadline is not a neutral administrative failure—it actively perpetuates research harm. When scientists are left navigating vague or contradictory rules, lifesaving research is delayed, innovation stalls and public health suffers.”
